
Epigenetic reactivation of a tumor suppressor program in AML
Inactivation of tumor suppressor genes (TSGs) confers a cellular fitness advantage to human cancer cells, including in acute myeloid leukemia (AML), where it disrupts myeloid differentiation and promotes leukemogenesis. Loss-of-function mutations in TSGs are frequently observed in patients with hematologic […]













